Matthew Krach is currently a Manager in Global Scientific Communications - Regulatory at Eli Lilly, where they work on the regulatory submission for Foundayo, focusing on weight management and Type 2 diabetes. They previously served as a Research and Development Team Lead at Ossium Health, contributing to the development of cell therapy products in clinical trials. Matthew holds a Doctor of Medicine degree from Indiana University School of Medicine and a Bachelor of Science in Biology and Theology from the University of Notre Dame. Their diverse background in medical assistance and research has equipped them with a unique perspective for the biotech industry.
Location
Indianapolis, United States
This person is not in the org chart
This person is not in any teams